Bristol-Myers Squibb Company (BMS, NYSE: BMY) announced a strategic agreement with artificial intelligence pioneer Anthropic...
CBC Group, the Singapore-based healthcare private equity firm, and Global Healthcare Opportunities (GHO), the UK-headquartered...
Sanofi SA (NASDAQ: SNY) announced today positive data from the global ElevAATe Phase II clinical...
A federal jury in the U.S. District Court for the District of Massachusetts returned a...
Novartis AG (NYSE: NVS) announced today new data from the PSMAddition Phase III clinical trial...
The China Population Welfare Foundation, in partnership with Lilly (NYSE: LLY) China, unveiled this week...
Hybio Pharmaceutical Co., Ltd. (SHE: 300199) announced today a strategic partnership agreement with two undisclosed...
Shanghai ZJ Bio-Tech Co., Ltd. (SHA: 688317), a leading Chinese molecular diagnostic reagent specialist, announced...
Shandong Buchang Pharmaceuticals Co., Ltd. (SHA: 603858) announced today a comprehensive licensing agreement with fellow...
Bayer AG (ETR: BAYN) announced today that the U.S. Food and Drug Administration (FDA) has...
UCB (EBR: UCB) announced today Week 16 data from the BE BOLD Phase III clinical...
United Laboratories International Holdings Ltd (HKG: 3933) announced today it has received tacit approval from...
ImmuneOnco Biopharmaceuticals (Shanghai) Co., Ltd. (HKG: 1541) announced today the dosing of the first patient...
Bio-Thera Solutions (SHA: 688177) announced it has received marketing approval from the U.S. Food and...
GlaxoSmithKline plc (GSK) (NYSE: GSK) has restructured its vaccine business operations in China, splitting the...
Boston Scientific Corporation (NYSE: BSX) announced a strategic $1.5 billion investment for an approximately 34%...
Shanghai Henlius Biotech, Inc. (HKG: 2696) announced a strategic partnership with fellow Chinese biopharmaceutical company...
Lundbeck (OTCMKTS: HLUBF) announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has granted...
Nanjing Leads Biolabs Co., Ltd. (HKG: 9887) announced it has received regulatory clearance in China...
CSPC Pharmaceutical Group Ltd. (HKG: 1093) announced it has received clinical trial approval from China’s...